Press Releases

SAN ANTONIO, Oct. 29, 2019 /PRNewswire/ -- IM HealthScience® (IMH®), innovators of medical foods and dietary supplements, today announced favorable results from a real-world, 12-month, post-marketing safety surveillance study for Fiber Choice® prebiotic fiber supplements (chewable inulin f

TARRYTOWN, N.Y. and PARIS, Oct. 29, 2019 /PRNewswire/ --  First biologic approved in the European Union for adults with severe chronic rhinosinusitis with nasal polyposis (CRSwNP)Dupixent now approved in the EU for three type 2 inflammatory diseases: severe CRSwNP, severe asthma and moderate-to-severe atopic d

NEW YORK and LONDON, Oct. 29, 2019 /PRNewswire/ -- Partners Capital Investment Group, the Outsourced Investment Office serving sophisticated institutions and senior investment professionals in Europe, North America and Asia, held its Annual

MONTREAL, Oct. 29, 2019 /PRNewswire/ - Caprion is pleased to announce its leadership role in a Pre-Conference Workshop at the upcoming AAPS PharmaSci 360 conference, San Antonio, Texas. The workshop initiated by Caprion's team and led by Dr. Virginia Litwin, Vice-President of Flow Cytometry, wi

SAN ANTONIO, Oct. 29, 2019 /PRNewswire/ -- IM HealthScience® (IMH®) today announced favorable results from the longest-running post-marketing surveillance study of its type. This study, called Functional Dyspepsia Safety Update at 24 months (FDSU24), is a real-world

SEATTLE, Oct. 29, 2019 /PRNewswire/ -- RareCyte announces the launch of the of RarePlex® Developer Kits that uniquely enable customers to add their own biomarkers to RareCyte circulating tumor cell (CTC) assays in their own lab. Kyla Teplitz, Sr. Product Manager said, "The understanding of cancer heterogeneity and evolut

BURLINGTON, Mass., Oct. 29, 2019 /PRNewswire/ -- Decision Resources Group, www.decisionresourcesgroup.com, a premier provider of high-value healthcare data, analy

MARLBOROUGH, Mass., Oct. 29, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, announced today that several posters featuring INTASYL™ will  be presented at the Society for Imm

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2019 /PRNewswire/ -- Genome Medical, a leader in telegenomics clinical care, today unveiled Genome Care DeliveryTM, a technology platform

WELLINGTON, New Zealand, Oct. 29, 2019 /PRNewswire/ -- Volpara Solutions, an industry leader in cancer screening workflow, today announced the expansion of its global Medical Adviso